Affiliation:
1. Higher Medical School
2. Research Institute of Clinical Otorhinolaryngology MI. L.I. Sverzhevskogo
Abstract
The general practitioner encounters all three forms of insomnia: idiopathic, chronic and acute. Idiopathic and chronic patients should receive specialized care by neurologist, psychiatrist or sleep disorders specialists because they require deep differential diagnosis and complex treatment. Acute insomnia patients need quick help to prevent the negative health impact and chronisation of sleep disruption. In theRussian Federation, the GP has access to three kinds of sleep drugs: benzodiazepines, melatonin receptor agonists, antihistamines. However, modern benzodiazepines are unavailable inRussiaand older benzodiazepines can lead to dependence. Melatonin receptor agonists are not effective enough for acute insomnia. Among available antihistamines, doxylamine is the most convenient option in clinical practice. Doxylamine has a good profile of safety and efficacy, it is included in the local clinical guidelines for insomnia. Also, doxylamine is the only sleep drug available for pregnant women. This paper presents a portrait of doxylamine and comments on its clinical niches and contraindications. We also discuss the pharmacology of doxylamine, drug interactions, and prescription modes. There are also three clinical case studies, presenting the typical acute insomnia patients and logic for their evaluation, underlining key clinical features of this disorder.
Reference30 articles.
1. Melnikov A.Yu. Acute Insomnia: Natural Course and Correction Modalities. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(4):28–35. (In Russ.) doi: 10.17116/jnevro201911904228.
2. Polouektov M.G., Buzunov R.V., Averbukh V.M., Verbitskiy E.V., Zakharov A.V., Kel’manson I.A. et al. Project of clinical recommendations on diagnosis and treatment of chronic insomnia in adults. Consilium Medicum. Nevrologiya i revmatologiya = Consilium Medicum. Neurology and Rheumatology. 2016;(2):41–51. (In Russ.) Available at: https://con-med.ru/magazines/neurology/neurology-02-2016/proekt_klinicheskikh_rekomendatsiy_po_diagnostike_i_lecheniyu_khronicheskoy_insomnii_u_vzroslykh/https://con-med.ru/magazines/neurology/neurology-02-2016/proekt_klinicheskikh_rekomendatsiy_po_diagnostike_i_lecheniyu_ khronicheskoy_insomnii_u_vzroslykh/
3. Kovalzon V.M. The role of histaminergic system of the brain in the regulation of sleepwakefulness cycle. Phiziologiya cheloveka = Human physiology. 2013;39(6):13–23. (In Russ.) doi: 10.7868/s0131164613060088.
4. Bakker R.A., Nicholas M.W., Smith T.T., Burstein E.S., Hacksell U., Timmerman H. et al. In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonists. J Pharmacol Exp Ther. 2007;322(1):172– 179. doi: 10.1124/jpet.106.118869.
5. Simons F.E.R. Advances in H1-antihistamines. N Engl J Med. 2004;351:2203–2217. doi: 10.1056/NEJMra033121.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献